Specificities, properties, and clinical significance of antiprothrombin antibodies

被引：48
作者：
Amengual, O [1 ]
Atsumi, T [1 ]
Koike, T [1 ]
机构：
[1] Hokkaido Univ, Sch Med, Dept Med 2, Kita Ku, Sapporo, Hokkaido 0608638, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 04期
关键词：
D O I：
10.1002/art.10831
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：886 / 895
页数：10
相关论文
共 73 条
[1]   Relationship between clinical features and binding domains of anti-prothrombin antoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome [J].
Akimoto, T ;
Akama, T ;
Kono, I ;
Sumida, T .
LUPUS, 1999, 8 (09) :761-766
[2]  
Amengual O, 1996, BRIT J RHEUMATOL, V35, P1239
[3]  
Arnout J, 1996, THROMB HAEMOSTASIS, V75, P536
[4]  
ARVIEUX J, 1995, THROMB HAEMOSTASIS, V74, P1120
[5]  
Atsumi T, 2000, ARTHRITIS RHEUM-US, V43, P1982, DOI 10.1002/1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO
[6]  
2-2
[7]  
BAJAJ SP, 1983, BLOOD, V61, P684
[8]   ACQUIRED HYPOPROTHROMBINEMIA DUE TO NONNEUTRALIZING ANTIBODIES TO PROTHROMBIN - MECHANISM AND MANAGEMENT [J].
BAJAJ, SP ;
RAPAPORT, SI ;
BARCLAY, S ;
HERBST, KD .
BLOOD, 1985, 65 (06) :1538-1543
[9]  
Bertolaccini ML, 1998, J RHEUMATOL, V25, P1104
[10]  
BEVERS EM, 1991, THROMB HAEMOSTASIS, V66, P629
12345678